Meeting
2021 ASCO Annual Meeting
Clinicogenomic characterization of metastatic thymic epithelial tumors.
Authors
Fatemeh Ardeshir-Larijani
Indiana University, Melvin and Bren Simon Cancer Center, Indianapolis, IN
Fatemeh Ardeshir-Larijani , Milan Radovich , Bryan P. Schneider , Patrick J. Loehrer Sr.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Thymic Malignancies
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 8579)
DOI
10.1200/JCO.2021.39.15_suppl.8579
Abstract #
8579
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Distinct mutational landscapes characterize melanomas metastatic to different anatomical sites.
First Author: Mahesh Y. Iddawela
Poster
2022 ASCO Annual Meeting
Lenvatinib for the treatment of thymic epithelial tumors (TETs): A real-life multicenter experience.
First Author: Jose Carlos Benitez
Poster
2018 Genitourinary Cancers Symposium
Phase II trial of palbociclib (PD-0332991) in patients with metastatic urothelial cancer (UC) after failure of first-line chemotherapy.
First Author: Tracy Lynn Rose
Poster
2017 ASCO Annual Meeting
Molecular analysis of thymic epithelial tumors (TETs): A report by The Cancer Genome Atlas (TCGA) research network.
First Author: Patrick J. Loehrer Sr.